So Pfizer wants to launch 12 NEW drugs in China by 2025, wowthat's launching one NEW drug every 2 months. Well that boxes in very nicely because the prior Investor Deck (not the current one) indicated cannabinoid API's to be a $25 BILLION DOLLAR MARKET by 2025 as well. At the rate of the FDA and status of existing U.S. clinical trials, that's makes it an impossibility to obtain that type of growth within the U.S. and especially, on average, 1 NEW drug every 2 months. But that type of growth for NEW drugs is very realistic when addressing over a 1 billion population in China. I am so happy that a traditional pharmaceutical company has LABS as a partner.